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Foreword by Mr. Pat Carey T.D., Minister for Community, Equality & 
Gaeltacht Affairs  
 
When I became Minister responsible for the National Drugs Strategy for the second 
time, I was struck by how much had been achieved by the Sector in the relatively 
short period since the first time I held that office.  The new strategy was already in 
place with a new structure based on specific targets and actions to be achieved over 
the life of the Strategy.  It is going to take us some time, but I think that our strategy is 
the right one and is achievable. 
 
The challenges remain formidable.  Our impact must remain equal to those challenges 
even with diminishing financial and human resources available to us.  We need more 
than ever to focus on the task and to work together to a much greater extent to ensure 
our efforts are effective. 
 
It is in this context that I am very pleased at this time to introduce the revised 
Handbook for Drugs Task Forces.  The Drugs Advisory Group has worked hard to 
ensure the Handbook is a useful tool for the Local and Regional Drugs Task Forces 
who work with such commitment in their communities to respond to issues in relation 
to drug misuse.   
 
Drug misuse is a cross-cutting issue which requires organisations and individuals 
from the community, voluntary and statutory sectors to develop an integrated 
response, based on a partnership approach.  Drugs Task Forces have gained solid 
recognition and credibility as a result of their work up to now.  Their work has 
focussed in particular on profiling and highlighting drugs misuse issues within their 
areas and developing projects to address gaps in services particularly in the areas of 
education/prevention, treatment/rehabilitation and supply reduction. 
 
A team-based approach is implicit in the task force concept.  As the Taoiseach 
emphasised in his foreword to the National Drugs Strategy, real partnership has been 
very evident across the initiatives of the National Drugs Strategy, both at national 
level and at local level, especially through the work of the Drugs Task Forces.    
 
This handbook has been developed within the context of the institutional structures 
recommended under the National Drugs Strategy 2009-2016 and within the overall 
framework of the National Social Inclusion Plan 2007-2016.  It sets out the role of the 
Drugs Task Forces within the national and local framework required to address the 
existing and emerging problems associated with drug use for individuals, families and 
communities in the context of the long term development of the work of the Drugs Task 
Forces.  
 
I have said on a number of occasions during the process of drawing up this revised 
handbook that it is not something set in stone.  I see it as a work in progress which 
should be reviewed regularly.  I see it as an enabling rather than regulating document, 
providing a context for the work of the Drugs Task Forces.    Matters of detail can be 
addressed in guidelines and procedures which will issue from time to time from the 
Office of the Minister for Drugs and the Drugs Advisory Group.   
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I wish the Drugs Task Forces every success.  I commend their members for their 
dedication and commitment and I look forward to continued co-operation with them to 
achieve to the greatest extent possible the strategic aims of the National Drugs Strategy 
between now and 2016.  
 
 
 
 
________________________ 
Pat Carey, T.D. 
Minister for Community, Equality and Gaeltacht Affairs. 
 
 
February 2011 
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INTRODUCTION 
 
This handbook has been developed within the context of the institutional structures 
recommended under the National Drugs Strategy 2009-2016 and within the overall 
framework of the National Social Inclusion Plan 2007-2016.  It sets out the role of the 
Drug Task Forces within the national and local framework required to address the 
existing and emerging threats from problem drug use.  
 
The handbook sets out the following aspects of Task Force processes: 
 
 Role of the Task Force  
 Composition 
 Role and Nomination Process of Members  
 Supports 
 Monitoring/ Evaluation/ Mainstreaming of Projects 
  
It has been developed by the Drugs Advisory Group (DAG) following consultation with 
Local and Regional Drugs Task Forces, Statutory Agencies and the Community and 
Voluntary sectors.  It may be subject to amendment.  Amendments may arise in 
particular from the further implementation of certain actions in the National Drugs 
Strategy 2009-2016, in particular in relation to co-ordination. 
 
The overall strategic objective of the National Drugs Strategy 2009–2016 is to continue 
to tackle the harm caused to individuals and society by the misuse of drugs, through a 
concerted focus on the five pillars of supply reduction, prevention, treatment, 
rehabilitation and research. 
 
The following are the overall aims of the Strategy: 
 To create a safer society through the reduction of the supply and availability of 
drugs for illicit use; 
 To minimise problem drug use throughout society; 
 To provide appropriate and timely substance treatment and rehabilitation services 
(including harm reduction services) tailored to individual needs; 
 To ensure the availability of accurate, timely, relevant and comparable data on the 
extent and nature of problem substance use in Ireland; and 
 To have in place an efficient and effective framework for implementing the 
National Substance Misuse Strategy. 
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A wide range of statutory, community and voluntary sector organisations are currently 
involved in delivering the National Drugs Strategy at national, regional and local 
levels. Since the inception of Drugs Task Forces in 1997, it is clear that effective 
action against drugs requires a sustained, coordinated effort across a range of 
Government Departments and Agencies working alongside community and voluntary 
services.  The National Drugs Strategy 2009-2016 has put in place a new coordinating 
structure to oversee the implementation of the strategy. The new strategy considers 
that engagement on the drugs issue with the Cabinet Committee on Social Inclusion, 
on a regular basis, is vital. The new structure will continue to allow issues of critical 
importance emerging at community level to inform Government through the 
established link with the Cabinet Committee on Social Inclusion. 
 
 
Drugs Advisory Group  
The primary function of the DAG is to advise the Minister/Minister of State on 
operational and policy matters relating to the National Drugs Strategy 2009 – 2016, 
working to: 
 support and drive the implementation of the NDS, primarily at local and regional 
levels;  
 ensure effective co-ordination between Departments and Agencies, including their 
timely input into operational and policy developments so as to positively influence 
programme and resource allocations in relation to drugs issues; 
 facilitate and support the engagement of the community and voluntary sectors in 
their roles in the NDS;  
 oversee and support the work of the Local and Regional Drugs Task Forces, 
ensure that policy is informed by their work and provide a liaison, reporting and 
representational role between the Task Forces and the Office of the Minister for 
Drugs; and  
 support the work of the Oversight Forum on Drugs and provide such reports to it 
as may be necessary from time to time.   
 
As part of the above, the Group will provide appropriate input into: 
 the development of an overall performance management framework to assess and 
monitor  progress across the National Drugs Strategy; 
 identifying and prioritising the budgets of their Departments/Agencies for drug-
related initiatives in the context of the annual Estimates process; 
 the incorporation by Departments/Agencies of the contribution to the work of the 
National Drugs Strategy into their strategy statements, business plans and annual 
reports; 
 the production of twice yearly reports from Departments/Agencies on drug-related 
expenditure, outputs and outcomes; 
 the production of twice-yearly reports on expenditure and activity from drugs task 
forces, in the context of their ongoing liaison roles; and  
 the production of an annual report on progress under the NDS. 
 
In this way it is intended that progress in advancing the Strategy will be supported, and 
issues and/or blockages arising will be identified and addressed. 
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Office of the Minister for Drugs 
The Office of the Minister for Drugs (OMD) within the Department of Community, 
Equality & Gaeltacht Affairs has been established to facilitate greater coherence in 
policy - making and service delivery.  Its purpose is to support and drive the ongoing 
implementation of the NDS, while respecting the various lead roles and statutory 
responsibilities of the Departments/agencies involved. Some of the key features of the 
Office include national co-ordination of the interagency implementation; policy 
development informed by the work of all the coordinating structures; and supporting 
the work of Drugs Task Forces. The OMD will also ensure that effective links 
continue with other key coordinating bodies such as the NACD and the NDRIC. 
 
Oversight Forum on Drugs  
The Oversight Forum on Drugs (OFD) is chaired by the Minister/Minister of State 
with responsibility for Drugs Strategy and is comprised of senior representatives from 
all sectors and Government Departments and Agencies. It’s primary role is the high - 
level monitoring of progress being achieved across the Strategy. Its Terms of 
Reference are to: 
 address operational difficulties and blockages in implementing the NDS and agree 
on appropriate ways forward to overcome these difficulties; 
 monitor progress on associated mainline services with a view to influencing 
outcomes; 
 to provide any reports on existing actions and details/rationale of future plans 
sought by the Minister of State, as chairperson of the Forum; 
 consider developments in drugs policies, and in dealing with problem drug use 
      generally, at EU and international level; and  
 to discuss and agree, as far as possible, on the approach to drugs issues at the 
Cabinet Committee on Social Inclusion, Children and Integration. 
 
Drugs Advisory Group Liaison 
The role of the DAG Liaison person on the Drugs Task Force is: 
 To attend meetings of the Drugs Task Force;  
 Attend the Drugs Advisory Group meetings and raise relevant issues; 
 To provide feedback to the Local/Regional Task Force on the work of the Drugs 
Advisory Group and on the work of the OMD in relation to the overall 
implementation of the National Drugs Strategy; 
 To assist the Task Force in its work, through the provision of procedural and other 
appropriate advice; 
 To bring information, ideas and proposals raised by the Task Forces to the 
attention of the Drugs Advisory Group and/or the Office of the Minister for 
Drugs, as appropriate, and provide feedback, as necessary; 
 To highlight problems emerging which need the attention of the Drugs Advisory 
Group and/or the Office of the Minister for Drugs; 
 To assist, as appropriate, where difficulties arise which cannot be resolved at local 
or regional level; 
 To give advice to Drugs Task Force co-ordinators and chairpersons, as necessary; 
and 
 To maintain an independent status - the liaison representative is not a voting 
member of the Task Force. 
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Notes: 
It should be noted that contact between the liaison person and the Drugs Task Force is 
just one of a number of channels of communication between the Office of the 
Minister for Drugs and the Drugs Task Forces. Other channels include: 
 
 Ongoing communication between the OMD and Drugs Task Force support staff 
regarding various operational matters (approval of funding, interim funding 
applications, etc.); 
 Regular meetings between the OMD and the Chairpersons and Co-ordinators 
Networks; 
 Attendance of the LDTF and RDTF Co-ordinators’ Networks on DAG sub-
committees.   
 
Alcohol  
 
The Local and Regional Drugs Task Forces’ role with respect to alcohol will be 
determined within the context of the development of the National Substance Misuse 
Strategy. 
 
 
 
A note on abbreviations - the following abbreviations are used throughout: 
 
DTF Drugs Task Force 
LDTF Local Drugs Task Force 
RDTF Regional Drugs Task Force 
NDS National Drugs Strategy 
OMD Office of the Minister for Drugs 
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SECTION I 
 
Role of Drugs Task Forces 
 
The National Drugs Strategy recognises the key role that Local and Regional Drugs 
Task Forces continue to play in addressing the drugs problem.  It remains important, 
therefore, that they operate effectively at community level with clear objectives and in 
accordance with appropriate guiding principles. 
 
Guiding principles for the operation of DTFs 
 
Propriety 
 DTFs will carry out their terms of reference (functions) with integrity and 
fairness and without self-interest or favouritism. 
 
Responsiveness 
 DTFs will be responsive to stakeholders’ views and will consult with them in 
carrying out their functions. 
 
Transparency 
 DTFs will keep their stakeholders informed about their policies and actions. 
 
Accountability 
 DTFs will be accountable for the use of public monies provided to them. 
 
Efficiency and effectiveness 
 DTFs will have regard to the need for effectiveness and efficiency in carrying 
out their terms of reference (functions). 
 
Partnership 
 DTFs work in a spirit of partnership between the statutory, voluntary and 
community sectors. 
 
 
Terms of Reference 
 
The original terms of reference of the Drugs Task Forces required them to assess the 
extent and nature of the drug problem in their areas and to develop and monitor the 
implementation of action plans to respond to the problem as identified. The Drugs Task 
Forces’ role is, by the use of an innovative and evidence-based approach in accordance 
with the National Drugs Strategy and in co-operation with the Drugs Advisory Group 
(DAG) and the Office of the Minister for Drugs (OMD), to focus on the delivery of 
these objectives within a local/regional context so as to ensure the development of a co-
ordinated and integrated response to drug misuse by: 
 
 Creating and maintaining an up-to-date overview on the nature and extent of drug 
use and misuse and the services available in the area/region through the gathering 
of all relevant information from the organisations and services involved; 
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 To strengthen and support a community based focus to drug and alcohol misuse, 
mobilising an integrated cross-sectoral response at local level;   
 To oversee and monitor the effectiveness of  projects approved under action plans 
and make decisions on continued priorities having regard to current needs and 
available funding; 
 Providing for the implementation of a local/regional strategy in the context of the 
National Drugs Strategy 2009 - 2016 through: 
o Identifying emerging strategic issues and developing proposals on policies 
or actions needed to address them;  
o Preparing updated action plans having regard to evidence available on the 
extent and specific location of illicit drug use in the area/region; 
o Seeking to influence the work of all relevant Statutory, Community and 
Voluntary service providers to improve services; 
o Identifying any barriers to the efficient delivery of services to clients in the 
Drugs Task Force area; 
o Developing Cross Task Force initiatives and networking arrangements for 
the exchange of information and experience with other Drugs Task Forces, 
as well as for the dissemination of best practice; and 
o Co-ordinating their activities with other relevant initiatives/programmes in 
the region, particularly those involved in responding to social disadvantage 
 Monitoring and evaluating the implementation of projects with a view to their 
continued funding through State Agencies in accordance with agreed procedures;  
 To ensure appropriate representation by the statutory, voluntary and community 
sectors on the Task Force & ensuring the appropriate induction and training of 
Task Force members; 
 Drugs Task Forces also have a role in informing national policy formulation;  
 To develop networking arrangements for the exchange of information and 
experience with other Task Forces, as well as the dissemination of best practice; 
 To take account of and contribute to other initiatives aimed at improving social 
inclusion and tackling disadvantage: Young People’s Facilities and Services Fund, 
Joint Policing Committees, Local Policing Fora, School Completion Programme, 
Revitalising Areas by Planning, Investment and Development (RAPID), 
Community Development Projects, and Area Partnerships; 
 To provide such information, reports and proposals to the Office of the Minister 
for Drugs as may be necessary from time to time; and 
 To regularly review its own operation and performance to ensure its continued 
effectiveness in fulfilling its Terms of Reference. 
 
Accountability arrangements 
 
 Each DTF will develop a local three year strategy, reflecting local needs and 
circumstances, to support implementation of the national drugs strategy; 
 Each year a DTF will identify priorities and actions (an operational plan) for the 
coming year, in line with nationally agreed priorities; 
 Each DTF will report on its activities, and in particular on its effectiveness and 
efficiency, twice a year to the Office of the Minister for Drugs in accordance with 
guidelines published by the office; 
 Each DTF will put in place accounting arrangements, based on receipted 
expenditure, in relation to any public funds disbursed by it and will report annually 
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on its expenditure of public monies.  These arrangements to be in accordance with 
any guidelines issued by the OMD for administration and operational budgets. 
 
Relationship between DTFs 
 
DTFs are to work closely together to promote networking arrangements, exchange 
information and experience and facilitate the dissemination of good practice with each 
other and other relevant bodies. There may be opportunities for some DTFs to tackle 
issues or develop services on a cross task force basis e.g. Dial to Stop Drug Dealing, 
rehabilitation services, etc.. 
Drugs Task Forces will continue to work within the following broad areas of 
responsibility: 
 
The LDTFs will: 
 continue to have the primary responsibility for the development and 
implementation of a local drugs strategy for their areas; and 
 contribute to strategic planning, policy making and the development of services for 
the region as a whole. 
 
The RDTFs will: 
 co-ordinate the development of drug programmes and services in the non-LDTF 
parts of the region; and 
 In conjunction with the LDTFs, co-ordinate strategic planning and policy making at 
regional level, including the development of services which might more effectively 
be delivered on a regional basis.  These could include, for example, treatment 
referrals, services for travellers, homeless persons and sex workers involved in 
illicit drug use, training for drug workers, etc. 
 
The status and boundaries of a Drugs Task Force will not be altered without prior 
consultation and negotiation with OMD. 
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Relationship between DTFs & Young People’s Facilities & Services Fund (YPFSF) 
The YPFSF assists in the development of youth facilities and services in disadvantaged 
areas where a significant drug problem exists or has the potential to develop.  The focus 
of the Fund, to date, has been on the 14 Local Drugs Task Force areas as well as 
Limerick, Waterford, Carlow and Galway, with the addition of Athlone, Dundalk, 
Wexford and Arklow in 2008.  Local Development Groups comprising of 
representatives from the relevant Local Authority, the VEC and a Task Force 
representative, are responsible for overseeing the effective implementation of the plans.  
The Task Force should be regularly updated by its representative on the Development 
Groups on the implementation of the plans and development of youth based services.  It 
should also be consulted in relation to any major changes or developments.  
 
Media Protocol  
If any Task Force member is contacted directly by a member of the media to  comment 
on the views of the Task Force, the concerned party should be referred to the Task 
Force Chairperson or Co-ordinator.  
 The Chairperson, as an independent representative of the DTF, should deal with 
any contentious issues that may arise in this regard. 
 The Chairperson or Coordinator should consult with the relevant Task Force 
members in relation to such media queries.   
 
Operational Guidelines 
 
It is best practice that rules for the operation of Drugs Task Force meetings and sub-
committee/working group meetings, outlining requirements around attendance and 
decision-making should also be agreed, in accordance with normal procedures and 
outlined in each Drugs Task Force’s agreed Operational Procedures.  
DTFs should have appropriate operational guidelines in place to support their work.  
These Guidelines should include the following: 
 Meetings of the DTF will be held at least once a month; 
 A quorum for meetings will be one third of the membership of the DTF; 
 A special meeting of the DTF may be called at the request of a quorum of the 
members; 
 Generally, decisions of the DTF will be taken by consensus; 
 Where a consensus cannot be achieved, a vote will be taken; 
 The Chair shall have the casting vote in the case of a split vote; 
 Decisions will be recorded as decisions of the DTF and individual positions should 
be noted. 
DTF Sub-Committees 
While it will be a matter for each DTF to determine its precise structures/working 
arrangements, it is envisaged that it may wish to establish a number of sub-committees 
to progress its work and support the Task Forces in the implementation of its strategy. 
These may be set up on a thematic and/or geographic basis, this being a matter for the 
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DTF to determine having regard to local circumstances.  Thematic sub-groups based 
around the pillars of the NDS work better than geographic sub-groups. 
In relation to Sub-Groups: 
 
 They should report back to their Task Forces and are not decision making bodies 
unless specifically mandated by the Task Force to be so; 
 The chairperson of the sub-group should be a member of the Task Force but sub-
groups may co-opt appropriate outside members as they see fit to assist in their 
work;  
 All Sectors (where appropriate) Community, Public, Statutory and Voluntary, 
should be represented; and 
 They should have agreed Terms of Reference. 
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SECTION II 
 
Composition of Drug Task Forces 
Membership of the DTFs 
 
Membership must include Community representatives, Voluntary representatives and 
key Statutory Agencies.  Each DTF should be chaired by an independent chairperson 
and should include representation from the following sectors/agencies: 
 Community Sector 
 Voluntary Sector 
 Public Representatives  
 Department of Education and Skills/VEC 
 FÁS 
 Garda Síochána 
 Health Service Executive 
 Local Authorities 
 Probation Service 
 Revenue Commissioners (Customs & Excise Division) 
 Department of Social Protection  
 Area Based Leader Partnership Companies/Community Development projects 
 City/County Development Boards  
 Service Users  
 Communities of Interest 
 
Task Forces may wish to consider seeking representation (at Task Force or Sub Group 
level) from other sources in light of their own needs and the needs of the communities 
they serve. 
Community Sector 
 
Community representatives, to a maximum of six, should be nominated to each Drugs 
Task Force following extensive consultation among local community groups and 
community fora. Nominations for representatives should be based on the following 
criteria: 
 Having an appropriate and adequate geographic spread of representation for the 
area; 
 Giving priority to groups with a strong track record in community development; 
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 Nominating individuals who have the relevant knowledge and experience of the 
drugs issue necessary to play a full and productive role on the Drugs Task Force; 
and 
 Nominating representatives who have the active support of the communities they 
represent. 
These criteria continue to apply when replacing community representatives for any 
reason, e.g. at the end of their term, resignations, etc. 
 
Voluntary Sector 
 
Voluntary representatives are nominated as set out in Section IV (Pg. 28). Criteria for 
nomination will include: 
 Giving priority to groups with a strong track record in drug treatment, rehabilitation 
or prevention and who are working in the area; 
 Nominating individuals who have the relevant knowledge and experience of the 
drugs issue necessary to play a full and productive role on the Drugs Task Force; 
and 
 Recognising the need for representatives to report to the voluntary drug sector as a 
whole rather than solely to their own voluntary agency. 
 
Statutory Agencies 
Departments/Agencies, in nominating their representatives, are required to take 
account of the need to nominate persons who are at a sufficiently senior level, or have 
access to people in their organisation who are in a position to influence policy. 
Departments/Agencies are also required to ensure that their representatives’ work 
with the Task Forces is seen as part of their core duties and that they have the 
necessary time available to them to enable them to undertake their role effectively 
(see Section III Pg. 22). To ensure a strong and active role by the statutory sector, it is 
important that statutory representatives have proper organisational supports and the 
necessary back-up arrangements. 
 
Elected Representatives 
 
The participation of elected representatives, on the same basis as other members, allows 
them to bring their considerable experience and intimate knowledge of the area to bear 
on the process. It also affords them an opportunity to influence the drugs strategy being 
developed by the Task Force for the area and to gain community support for it. 
 
Service Users 
It is important that the views of service users are represented on the Drugs Task Forces.  
They have a unique perspective on the policies/services being developed.  The active 
participation by service users at Drugs Task Force or Sub Group level is to be 
encouraged and facilitated to add to the knowledge base of the Drugs Task Forces and 
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help to focus on practical actions of direct benefit to those for whom the services are 
being provided. 
 
To facilitate such participation, it will be necessary to develop service users fora, 
building on the work by DTF projects and service providers around their own service 
user participation structures, from which representatives can be nominated to the DTF.   
Each Drugs Task Forces should endeavour to establish a forum for its area/region, 
making it a key priority for development workers to develop and support such a forum 
in each Task Force area.  Other forms of representation for the needs of service users 
should be in place where such fora have not yet been established. 
 
Communities of interest 
The ‘communities of interest’ involved in any initiative can vary, depending on the 
issue being addressed and to the extent to which it impacts on them. It will be a matter 
for each DTF to agree locally or regionally how groups representing communities of 
interest will participate in the work.  The remit of organisations from the voluntary 
and community sectors, already represented, is to address the extent to which the 
problems involving these client groups impact on the area.  
 
 
LDTFs & RDTFs 
 
In areas where Regional Drugs Task Forces & Local Drugs Task Forces co-exist it is 
important that there is ongoing co-operation and co-ordination and close links 
maintained. 
 
City/County Development Boards 
 
Similarly, the City/County Development Boards, who are responsible for developing a 
co-ordinated strategy for the social, economic and cultural development of their areas, 
may also be invited to participate in the work of the DTFs. This participation could be 
through the Social Inclusion Measures Groups, which operate under their aegis, through 
the Directors of Community & Enterprise. 
 
Duration of Appointment/Review of Representation 
 
There are no formal guidelines regarding the term of office of appointees to Drugs 
Task Forces.  Generally, their tenure should be such as to ensure continuity and 
consistency in the approach of the Drugs Task Force in responding to the drug 
problem in its area (see Section IV Pg. 28).  
 
In this regard, statutory representatives continue to be nominated to the Drugs Task 
Forces by their agencies, having regard to those agencies’ responsibilities towards the 
initiative as outlined in Section III (Pg. 22). 
 
Drugs Task Forces are required to ensure that appropriate procedures are in place to 
assist them with the election of the Chairperson and the appointment of members to 
the Task Force.  A regular review of representation will take place. Rules for 
attendance at Drugs Task Force meetings and sub-committee/working group 
meetings, and for decision-making and confidentiality of proceedings, should also be 
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agreed, in accordance with normal procedures.  Drugs Task Force members should 
sign a commitment to abide by these rules. 
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SECTION III 
 
Role of Drugs Task Force Members 
The Drugs Task Forces are given a key role by the Government in responding to the 
drug problem. Their composition reflects the need to ensure locally-based responses 
that complement existing or planned drug programmes and services. In this context, the 
part played by individual Drugs Task Force members in representing their particular 
agencies or sectors is pivotal to the success of the initiative and demands active 
participation in all the Drugs Task Force’s work, including decision-making. The 
establishment of the DTFs gives the statutory, community and voluntary sectors, as 
well as public representatives, a unique opportunity to work together in preparing and 
implementing an integrated strategy to address the issues relating to drug use & misuse. 
This requires the development of shared values, which promote co-operation and 
collaboration. For this to happen, however, it is important that all involved are clear as 
to their roles and responsibilities. 
 
It is the role of all DTF representatives to ensure that all relevant information 
available to their organisations should be provided to the DTF for the purpose of 
developing a 'Community Profile.’  As outlined in the NACD Report “A Community 
Drugs Study: Developing Community Indicators for Problem Drug Use (2006)”, this 
information could include: 
 
 A profile of the range of drugs being used.  Information from the HSE regarding 
Methadone Treatment Data and the Health Research Board regarding data from 
the National Drug Treatment Reporting System to feed into this profile; 
 A profile of the local housing development, including warnings of and actual 
evictions and use of public spaces; 
 A profile of the Drug Related Deaths in the area; 
 A profile of crime and community safety in the region, for example, criminal 
justice issues (seizures, public order and anti-social arrests and charges, 
acquisitive crime, seizures/ number of cases sent for forensic analysis, Garda Data 
on known opiate users); 
 Social Capital- Informal Social Support Networks: structure, density and size and 
composition by age, gender, ethnicity etc. Also a profile of community 
participation/volunteering; and 
 School attendance. 
 
Chairperson 
 
The Chair is appointed by the Task Force for a three-year term.  The Chairperson is a 
key figure and the success of the DTF will very much depend on the level of 
experience, commitment, skills and energy s/he can bring to the role. The Chairperson’s 
independence must clearly be established and evident in the manner in which the 
business of the TF is conducted. It is important therefore, that the Chairperson 
appointed by the Task Force is not directly connected with any of the projects being 
funded by the Task Force.  It is also important that there is complete transparency in the 
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arrangements put in place by DTFs for the selection process and appointment of Chairs.  
The Chairperson’s role is to lead the Task Force and to facilitate its meetings.  
 
Leading the Task Force 
 
The key responsibilities which arise here are: 
 ensuring the Drugs Task Force works together towards achieving its aims; 
 acting as spokesperson and representing the Drugs Task Force, as appropriate; 
 overseeing the development, implementation and monitoring of an annual work 
programme by the Drugs Task Force; 
 helping to resolve conflict; and 
 convening meetings of the Executive Sub-Committee to make emergency decisions 
between meetings, where necessary, in accordance with procedures agreed by the 
Task Force 
 
Facilitating meetings 
 
This involves: 
 helping members to work well together in discussing and deciding issues; 
 encouraging all members to participate fully and ensuring that they are heard; 
 suggesting ways of dealing with conflict and ensuring that it is not ignored; and 
 ensuring that members are aware of their responsibility to make meetings effective. 
 
It is important that the Chairperson has the ability to bring together organisations and 
individuals from the different sectors to work as a team. It is also desirable that s/he has 
a knowledge and experience of social inclusion issues in the area/region, particularly as 
they relate to illicit drug use.   
S/he must also be able to give an assurance of their availability in relation to time 
requirements necessary to carry out the job.  This will entail attending meetings of the 
DTF and, where appropriate, meetings of its sub committees; attending national and 
regional meetings and conferences; as well as overseeing the effective implementation 
of the DTF’s work programme, in conjunction with the Co-ordinator. 
 
Vice-chairperson 
 
The vice-chairperson’s role is to chair Drugs Task Force meetings in the absence of the 
chairperson. 
 
Election of vice-chairperson should take place every three years following ratification 
of the chairperson.  
 
The same person may hold the posts of chairperson or vice-chairperson for not more 
than three consecutive terms and the same person cannot hold a combination of these 
posts for more than four consecutive terms. In as far as practicable, arrangements 
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should be made so that the term of office of the chairperson and vice-chairperson do not 
terminate at the same time 
 
Statutory Representatives 
Bringing Drugs Task Force projects to implementation stage and further developing the 
role of the Drugs Task Forces is a demanding task that requires significant support from 
the State Agencies. This needs on-going commitment, both at the level of the individual 
and the organisations they represent. Such commitment is essential if the various 
measures in the action plans are to be implemented and the plans themselves further 
developed. 
 
Statutory representatives are expected to carry out their role in a proactive way, 
bringing information from their organisations to the Drugs Task Force and looking at 
ways in which their organisation can develop innovative local responses to the drug 
problem. They must be mandated to act on behalf of their agencies in the planning, 
implementation and monitoring of the Drugs Task Force action plan. 
 
While statutory representatives have particular fields of expertise, they are expected to 
be familiar with all aspects of Drugs Task Force activities and the strategies being 
adopted to address the drug problem in their area. This enables them to participate 
actively in the work of the Drugs Task Force. The workload attached to DTF 
representation should be considered part of their core duties and adequate induction 
training provided to effectively carry out the duties as prescribed.  Representatives must 
attend meetings regularly and involve themselves in other Drugs Task Force activities, 
including participation in sub committees and working groups as required.  
This will also allow the DTFs to have a more direct input into the development of 
policies/practices at agency level. The statutory representatives will be expected to 
undertake a range of duties with the DTF, including: 
 bringing relevant information from their organisations to the DTFs; 
 assisting the development of appropriate responses to illicit drug use in the region; 
 identifying and ensuring the effective implementation of interim-funded projects 
and other initiatives including acting as channel of funding for projects that fall 
within the remit of their organisations; 
 
 monitoring projects being funded through their organisations and assisting with 
any issues that arise; there should be no undue delay in setting up projects which 
are approved funding. This includes the prompt processing of payments by State 
Agencies to project promoters, while at the same time ensuring the need for 
financial accountability and proper procedures. Project Promoters need to be 
aware of each organisation’s funding, monitoring and reporting requirements and 
kept informed of any changes in those requirements. Statutory representatives  
should monitor the situation in relation to projects being funded through their own 
organisations and ensure that any emerging problems are highlighted at an early 
stage, so that appropriate remedial action can be initiated; 
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 updating the DTF on any relevant changes in organisation practices and/or 
reporting arrangements in a timely fashion; 
 identifying and bringing to the attention of their agencies any proposed changes in 
policies/practices to ensure more effective coordination  with other stakeholders. 
 supporting project evaluations as required (Please also see Section VI below). 
 
The above role description is generic. It will be necessary for individual agencies to 
define the precise role of their representatives, having regard to the manner in which 
they are best structured to participate in the work of the DTF. In defining this role, the 
following should be taken into account: 
 the approximate amount of time allocated to the representative towards DTF work; 
 the information that the agency will provide through the representative to enhance 
policy development and decision making within the DTF; 
 the process for consulting the DTF on its own service plans/policies; 
 the process for assimilating information and ideas from the DTF into its 
policies/practices. 
 
The Drugs Task Force process provides a valuable opportunity to share ideas and 
experiences across a broad range of sectors and activities. Statutory representatives 
should actively engage with their counterparts on other Drugs Task Forces and 
representatives of other agencies, whenever possible, to maximise this potential benefit, 
broaden their understanding of the issues involved in addressing the drug problem and 
share best practice in relevant areas.  The relevant DAG representative will also 
convene meetings to inform and support this process. 
 
RDTFs have an additional communication issue as they service a wider geographical 
area. For example, numerous VECs could fall into one RDTF, while only one regional 
representative among them is nominated to the RDTF. Where this occurs, it is essential 
that there is a formal communication process to ensure that all representatives are 
informed.  Where multiple branches of the same agency fall within the one RDTF, the 
development of a formal communication process between the branches should be 
established 
 
Voluntary Representatives 
The voluntary sector makes a valuable contribution to the work of the DTFs. The 
experience gained by voluntary organisations from working directly with clients has 
enabled them to develop and promote innovative approaches to tackling illicit drug use.  
This, in turn, allows them to bring a unique perspective to the work of the DTFs.  
 
The voluntary representatives should belong to voluntary agencies that are either 
servicing or located in the region/area. The Voluntary representatives should 
demonstrate a good knowledge of the local drug problem, as well as a commitment to 
dealing with it. 
 
The role of the voluntary representative involves: 
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 providing information on the work of the DTF to the various voluntary 
organisations in the region to be done in a formalised manner through the local 
networks; 
 organising discussion and debate on that work among those organisations;  
 policy development; and 
 providing feedback to the DTF.  
 
Community Representatives 
People who are nominated as community representatives should be active within their 
communities, have some experience of local drugs issues and have a commitment to 
dealing with the problem. The extent of that experience will vary from area to area, as 
different communities are at different stages of development in responding to the drugs 
issue. However, as the work of the Drugs Task Forces continues, it is likely that the 
experience of newer representatives will increase, especially through their involvement 
with various projects and initiatives. Through their participation in the DTF, these 
representatives will: 
 bring to its work an in-depth knowledge of the local drug problem;  
 assist the development of policies/services based on a perspective gained from their 
involvement in the delivery of community-based services on the ground; and 
 represent the view of the local community at the Drugs Task Force and keep their 
community informed on the Drugs Task Force’s work. 
 
It is essential that the expertise and experience of the community sector is clearly 
recognised by the other sectors involved. 
 
It is recognised that community representatives are, in some instances, acting for 
communities where no adequate community structures exist. In representing the views 
of the local community, representatives will often have to deal with strongly divergent 
views. Therefore community representatives may require additional supports and 
training from DTFs to effectively fulfill this role. 
 
The community representatives are not members of the Drugs Task Force as 
individuals, nor are they there to represent the interests of any particular organisation. 
Rather, they are nominated as persons who can represent the interests of the wider 
community. Their role, therefore, is to bring the view of the sector to the Drugs Task 
Force and keep their sector informed on the Drugs Task Force’s work. 
 
There are three key processes involved in carrying out that role: 
 
 providing information to the local community; 
 organising and facilitating discussion and debate in the local community; and 
 providing feedback to the Task Force. 
 
In order to represent the views of the local community sector, the representatives need 
to be able to feed information back to Drugs Task Force meetings in an effective way. 
This involves their active participation not only in full Drugs Task Force meetings but 
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also on any sub committees or working groups of the Drugs Task Force. Community 
representatives should also be part of any delegations to meet the DAG or other 
relevant bodies. 
 
The community representatives should work together on summarising and presenting 
information to the Drugs Task Force and in promoting and arguing their case, where 
necessary. 
 
Public Representatives 
Public representatives will bring their knowledge of the illicit drug problem in the areas 
they represent to the work of the DTF.  As mentioned previously, they can also play an 
important role in consulting the local community on the DTF strategy and winning 
support for it. 
In this context, it is important that they are fully appraised of the DTF strategy and the 
reasons underpinning it so that, if necessary, they can assist the DTF in overcoming 
local misapprehensions or fears around the provision of services.  Representatives 
nominated to the DTF are expected to liaise with and encourage other public 
representatives in their areas to support its work.  
 
Other Representatives 
The Partnership, Local Drugs Task Force and Social Inclusion Measures Group 
representatives will assist in ensuring greater co-ordination and co-operation between 
their respective organisations and the DTF. 
They will be expected to keep the DTF informed of their strategies to address illicit 
drug use/social inclusion issues in their areas, as well as report back to their respective 
organisations on DTF activities. They will also be expected to assist the DTF in 
identifying/addressing areas of duplication or overlap in their respective strategies. 
 
Role of DTF members as Project Promoters 
The community/voluntary representatives are not members of the Task Force as 
individuals, nor are they there to represent the interests of any particular organisation. 
Rather, they are appointed as persons who can represent the interests of the wider 
community/voluntary sectors. Their role, therefore, is to bring the view of these sectors 
to the Task Force and keep their sectors informed on the Task Force’s work. 
 
A number of DTF members are involved in the management of projects being funded 
through the DTFs. 
Some voluntary representatives work with agencies that receive funding - additional to 
their core funding - to deliver specific interventions on behalf of the DTF.  In the case 
of the community sector, in view of the small numbers willing to become involved in 
drug work, it is often those who are asked to assist in developing policy that are also the 
most willing to become involved in the delivery of services on the ground, either in a 
volunteer or salaried capacity. In some instances, State Agencies are the promoters of 
DTF projects. 
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It is important that these representatives continue to have an input to DTF work, 
particularly in the context of tapping their knowledge and expertise.  However, there is 
equally a need for the representatives to differentiate between their roles as DTF 
members and project promoters so as to prevent a possible conflict of interest arising. 
Accordingly, it will be necessary for each DTF to have appropriate procedures in place 
to ensure that representatives from organisations that apply for DTF funding are not 
involved in the process of determining which projects are recommended for funding.  
This would involve absenting themselves from the relevant part of meetings when 
matters of funding for their projects are being discussed/decided. Care needs to be taken 
that equivalence of consideration is given by a Task Force to funding applications from 
services that don’t have representation at the Task Force. 
In this way, these members can continue to bring their unique perspective, expertise 
and energy to the work of the DTFs - particularly those in direct contact with drug users 
- while at the same time avoiding any potential conflict of interest. 
 
Please refer to the Operational Guidelines for Drugs Task Forces to further inform this 
process. 
 
Networking 
Networking is an integral part of the process in that it allows the Drugs Task Forces to 
share their experiences and come to agreed solutions on common problems.  
Networking is facilitated in a number of ways as follows: 
 
Chairpersons Group 
The Chairpersons of the Task Forces hold ad-hoc meetings, as the need arises. 
Secretarial support and facilitation is available to them for this purpose.  The DAG also 
meets the Chairpersons group periodically. 
 
Co-ordinators Group 
The Task Force co-ordinators have formed a network group which meets regularly to 
discuss matters of common interest.  DAG meets regularly with this group.  
 
State Agency groups 
All statutory representatives should hold regular group meetings to ensure that 
individual concerns are addressed and that progress is monitored centrally. Statutory 
representatives are also expected to meet in plenary session as required, to ensure that a 
uniform drugs policy is reflected throughout all agencies and that there is an awareness 
of developments. 
 
DAG/OMD 
The relationship between the DAG/OMD and the Task Forces is perceived by all 
involved as being very important.  The liaison person from the Group is integral to this. 
 
Community Representative 
A crucial part of the role of the community representative is their coming together to 
identify issues of common concern, so as to have a joint input and impact on policy 
development and to feedback issues of concern to the DAG community 
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representatives. They are supported in this networking by Citywide Drugs Crisis 
Campaign who co-ordinates the community representatives’ networks.   
 
 
Local Structures 
A key function of Drugs Task Forces is to raise awareness of the drugs issue in other 
local community structures to inform policy making and effective service provision 
especially those relating to social inclusion and tackling disadvantage. Equally the 
work of Drugs Task Forces should be fully informed by developments in other 
structures such as  
 
 Local Development Companies (formerly Partnerships); 
 Community Development Programme projects; 
 RAPID Area Implementation Teams; 
 YPFSF Development Groups; 
 City & County Development Boards SIM Groups; 
 Children’s Services Committees; 
 Local Homeless Fora; 
 Joint Policing Committees; 
 Local Policing Fora. 
 
While it may not be possible to progress this through representation in all cases, other 
options include informal contacts and linkages and/or influencing/updating through 
statutory or other representatives where membership overlaps.  
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SECTION IV 
 
Nomination Process for Members of Task Forces 
The following is the nomination process for the various members. 
Chairperson 
The DTF chairperson will be elected directly by the DTF, although, in order to ensure 
that the most suitable person is selected, s/he need not necessarily be a representative of 
one of the participating bodies/sectors on the DTF. The criteria for nomination include: 
a relevant expertise, knowledge and experience of the drugs issue in the area and an 
assurance of the necessary time commitment to carry out the job. Task Forces should 
elect a vice-chairperson who is available to stand-in for the chairperson from time to 
time as required. 
 
Where the term of chairperson is coming up for renewal, it is recommended that Task 
Forces give notice of this well in advance to allow Task Force members an 
opportunity to reflect on the stewardship of the chairperson and to contribute to a 
meaningful discussion on the matter if required.  
 
Statutory Sector 
 
Each Department/Agency will nominate one representative to each DTF. In this 
context, it would be important that the representatives either work in a relevant area 
within their organisations or have direct access to those who do.  It is essential that they 
are at an appropriately senior level, so as to be able to influence policies/practices 
within their organisations.  
 
It is a matter for each Task Force to determine which Departments are invited to 
become full Task Force members and which are invited to participate at sub-group 
level. However there is an onus on Task Forces to structure their meetings to most 
effectively utilise the time and expertise of members particularly around matters of 
strategic importance.  
 
Voluntary Sector 
 
RDTFs 
 
The National Voluntary Drug Sector (NVDS) has established Voluntary Cluster 
groups in all ten Regional Drug Task Force areas. These cluster groups comprise 
representatives from all the voluntary sector agencies providing drug and/or alcohol 
services in the region or to the region. These cluster groups will be the nominating 
bodies for voluntary sector representatives on the RDTFs. Each cluster will nominate 
six persons to the Regional Drugs Task Forces who will be representative of the entire 
sector. 
 
The term of office of the voluntary representatives on the Regional Drugs Task Forces 
will be two years. 
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Local Drugs Task Forces 
 
Voluntary agencies delivering substance misuse services in or to the LDTF area will 
be represented by a maximum of 2 representatives on LDTFs. 
 
In order to strengthen Voluntary Sector representation on the Local TF’s voluntary 
representatives will be appointed following consultation between local agencies 
serving the area. Criteria for appointment will include; 
 
 Membership of local groups with a track record in provision of substance 
misuse services 
 Appointing people who have  the relevant knowledge and experience 
necessary to play a full and productive role on the Task Force 
 Appointing representatives who have the active support of the local services 
 Recognising the need for representatives to report to a local service network or 
cluster rather than their own agency. 
 
The term of office of the Voluntary representatives on the LDTF will be two years. 
 
The Voluntary and Community Sectors are committed to working together in 
supporting and networking their representatives on Task Forces. 
 
Community Sector 
 
The community sector will nominate not more than 6 representatives to the DTF. 
Ideally, like their voluntary counterparts, community representatives should be 
nominated through community networks. These networks would not only provide those 
nominated with a mechanism to consult with colleagues from their sector, but also a 
mandate to represent their views at the DTF. 
 
However, while work has commenced on the development of networks in RDTF areas, 
they remain largely undeveloped in most regions at present.  RDTFs should actively 
support the development of existing networks involved in drug work and encourage the 
setting up of new ones. This work is to be supported by RDTF Development Workers. 
Future community sector nominations to the RDTFs could then come from these 
networks.  
 
However, while work continues on the development of such networks, alternative 
arrangements for the nomination of community representatives may be required. 
Although, in areas where community groups/networks already exist or are in the 
process of being set up, it is essential that they play a role in the current nomination 
process. In such cases Task Forces may seek nominations from the County & City 
Development Boards or local Partnership structures which both facilitate community 
participation. In order to ensure that the most appropriate nominees are selected, the 
networks should ensure that those nominated: 
 live in the area from which they are nominated; 
 are fully committed to the aims and objectives of the DTF; 
 are able to give an undertaking of the necessary time commitment to carry out the 
role effectively; and 
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 have a good knowledge and experience of local drug issues, based either on 
personal experience or from working on a drug project in the area. 
 
The term of office of the community representatives will be two years. 
 
Communities of Interest 
 
It is important to recognise that, in addition to area-based communities, there may also 
be communities of interest, who can play an important role in the work of the DTFs and 
their participation should also be facilitated. Communities of interest may include:  
 Family Support Networks 
 Travellers 
 Lesbian Gay Bisexual Transgender (LGBT) Groups 
 New Communities 
 Homeless 
 Prisoners 
 Sex workers 
 
It will be a matter for each DTF to agree locally or regionally how groups representing 
communities of interest will participate in the work of DTFs having regard to the remit 
of organisations from the voluntary and community sectors already represented and the 
extent to which the problems involving these client groups impact on the area.  
 
Public Representatives 
 
A total of not more than 6 elected representatives will be nominated to the DTF.  Public 
representatives should be drawn from relevant local authorities (County/City/Urban).  
Members of Dáil or Seanad Éireann may also be invited to become members.  
 
At present, public representatives from County and City Councils may become 
members of Drugs Task Forces, at the invitation of the Task Force. Arrangements to 
facilitate the invitation of public representatives from Town Councils are currently 
being finalised with the Association of Municipal Authorities of Ireland. 
 
The term of office of the public representatives will be two years.  
 
Partnerships 
 
It is recommended that the Partnership managers in the region should form a network, 
which will nominate one representative to the DTF. 
This representative will bring the collective views of the network to the DTF, as well as 
report back on DTF activities to the network. The individual managers, in turn, should 
report back to their respective Partnerships. 
The Partnership Network will rotate its representative to the DTF at intervals to be 
agreed locally. 
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Duration of Appointment/Review of Representation 
 
Every effort should be made to ensure continuity and consistency in Drugs Task Force 
membership, however the need to reinvigorate the DTF and ensure a good geographical 
and representational spread should be taken into account. It is recommended that as part 
of their work plan each year, Drugs Task Forces would identify those members whose 
term of office is due to expire in the coming year and advise Drugs Task Force 
members accordingly. While statutory representatives continue to be nominated to the 
Drugs Task Forces by their agencies as vacancies arise, Drugs Task Forces should write 
to such agencies every two years to reaffirm statutory representatives.  Normally, the 
Chairperson should have a term of office of three years, and a Chairperson should serve 
a maximum of three terms, four in exceptional circumstances.  
 
It is equally essential that the chairperson and community/voluntary representatives 
continue to retain the confidence of both the Drugs Task Force and the sectors they 
represent.  All members should make every effort to ensure that adequate notice is 
provided in cases where members are stepping down from their roles on Drugs Task 
Forces.  It is desirable that replacements are put in place as quickly as possible to 
ensure continuity of representation and a period of overlap is provided for where 
possible to allow for induction and a smooth handover. 
 
Drugs Task Forces are required to ensure that appropriate procedures are in place to 
assist them with the regular review of representation.  
 
 
Induction, Training and Support for new Task Force Members 
Responsibility for induction of new members will lie with the Task Force Co-ordinator. 
New members are given a formal induction that includes: 
 The Drugs Task Force Handbook; 
 An induction meeting with the Chairperson and/or Co-ordinator; and 
 A mentor: an experienced member of the Task Force who undertakes to provide 
ongoing information and support for the first six months of the new member’s term. 
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SECTION V 
 
Supports for Drugs Task Forces 
 
A range of supports have been put in place to assist the Drugs Task Forces in their 
work. 
 
Co-ordinator 
A co-ordinator is appointed full-time to each Drugs Task Force. The co-ordinators are 
employed by the HSE who have responsibility for their conditions of employment and 
salaries. The co-ordinator, in conjunction with the DTF and its chairperson, plays a 
pivotal role in assisting the Drugs Task Force in developing and implementing its drug 
strategy.  This necessitates him/her taking a pro-active role in driving the work of the 
Drugs Task Force and managing its day-to-day operation, including the provision of 
project and financial information.  Some of the ways the co-ordinator supports the work 
of the Drugs Task Force include:  
 
 to profile services and resources available in the local area to combat drugs; 
 to ensure that the aims and objectives of the Drugs Task Force’s action plans are 
met through ongoing review, updating, prioritisation and amendment, including 
the initiation of any research required to inform such reviews; 
 to facilitate multi-sectoral collaboration through increased participation in the 
Drugs Task Force drug service provision within the area; 
 To support the Drugs Task Force in reviewing emerging needs and prioritising 
responses and helping to oversee the effectiveness of Drugs Task Force funded 
projects; 
 to disseminate information on local drugs issues, Drugs Task Force plans, services 
and other responses; 
 to liaise with key interest groups, service providers, Government Departments and 
other relevant groups; 
 to co-ordinate a range of activities of the Drugs Task Force  
 
Where a vacancy arises, the Drugs Task Force should seek the HSE representative to 
immediately initiate recruitment procedures to appoint a replacement and to make 
arrangements for the interim. The HSE should work closely with the Drugs Task Force 
in the recruitment process which ideally should include the Drugs Task Force 
Chairperson or vice–chairperson on any interview panel.  
 
The appropriate line manager within the Health Services Executive (HSE) will be the 
co-ordinator’s line manager, dealing with all normal personnel matters (annual leave, 
sick leave, etc.). 
 
Additional Support Staff 
Additional support staff in the form of an RDTF Development Worker and 
Administrator is provided for through the DTF Operational Budget. In the case of the 
LDTFs, staff are normally employed on a distinct funding line. 
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The Development Worker has a vital role in developing and supporting community 
based projects and facilitating interagency work. The key responsibilities of this post 
are project support, support of community/voluntary representatives and development 
of community/voluntary networks, policy development and the development of service 
users fora. They also support sub committees and can assist in the provision of project 
and financial information of projects. 
 
The key functions of the administrator include general office administration, financial 
monitoring of operational budget expenditure, meetings, keeping up to date on 
drugs/addiction information. 
 
Operational Support Costs 
 
The HSE has primary responsibility for providing and maintaining adequate 
administrative supports to the Task Force co-ordinators.  However a flexible approach 
is taken and the ability of other State Agencies to assist in the provision of back-up 
services and accommodation is explored, where appropriate, having regard to the level 
of services provided by those agencies in the area and particular needs of the Task 
Force. 
 
Task Forces are also permitted to include in their action plans, proposals for whatever 
additional supports are necessary - within their financial resources - to enable them to 
implement the plans. 
 
Administrative/Development Funding 
 
This funding will cover the costs of travel and subsistence, and childcare or carers costs 
for TF Chairpersons, community members and, in some instances, travel and 
subsistence for voluntary representatives, as well as other incidental expenses such as 
publishing DTF materials, advertising, public meetings, conferences, etc.  It may also 
be used to provide “seed” funding to new and emerging community or voluntary groups 
as a precursor to involving them more actively in the Task Force’s overall drugs 
strategy at a later date. 
 
Travel Expenses 
 
Due to the size of some regions transport costs will inevitably vary for community 
representatives and, in some instances, voluntary representatives. In general  
 
 Voluntary drug projects significantly funded by the State should be approached 
locally with a view to covering the costs of attendance at meetings from within 
their overall budget 
 Where necessary, exceptional cases that arise from the voluntary sector, will be 
assessed by a group comprising the DTF coordinator,  DAG liaison person and 
DTF chairperson. 
 HSE standard travel rates and claim forms should be used when making 
applications for refund of expenses for chairpersons, community reps, voluntary 
reps and public reps. 
 Standard HSE regulations/procedures will apply 
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 Public transport and shared travel arrangements should be encouraged where 
possible to keep down costs.  
 In all cases claims for recoupment should be made only on the basis of vouched 
invoices or receipts. 
 
Subsistence 
 
DTF meeting arrangements should ensure that payment of subsistence rates would not 
normally apply. However, meeting arrangements should include provision of 
refreshments for meeting participants as deemed necessary. 
 
Family care costs for community representatives and DTF chairpersons: 
 
Expenses incurred in relation to the care of the young, sick or elderly persons, while 
members are attending Task Force business, may be recouped on the basis of vouched 
invoices or receipts.  DAG acknowledges that there may be regional variations in the 
rates charged. 
In all cases members are asked to seek preapproval in accordance with official 
regulations.  The DTF Co-ordinator should work with members in this regard.  
Each DTF Co-ordinator as part of their preparation of their administrative budget 
should estimate their needs to meet travel and family care expenses for community 
representatives. 
 
Other Expenses 
Non routine expenses, including by chairpersons, must be agreed in advance by the 
Task Force. 
 
Substitution Costs 
 
The underlying principle governing the membership of the RDTF by community 
representatives, like the LDTFs, is that they do so on a voluntary basis. Therefore, 
payments by way of salary, fee payments or loss of earnings or for giving up their own 
time to attend meetings etc. are ineligible for funding.  The Voluntary Sector 
representatives will be mandated and resourced to attend meetings of the Task Force by 
agreement with the Voluntary Cluster for the region and the Project Service Provider 
from which they normally work.  In most cases the employing Project will remunerate 
the voluntary representative to attend meetings.  In some circumstances a local service 
provider may not be in a position to support a worker.  In these cases recourse may be 
taken to the Task Force as described earlier. 
 
Expenses for Public Representatives 
 
The Department of Community, Equality and Gaeltacht Affairs sanctioned expenses for 
Public Representatives up to an annual set limit per rep for attendance at Regional 
Drugs Task Force meetings. Expenses to be claimed from RDTF Co-ordinator. 
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Additional Supports 
 
Supports for Community Sector Representatives 
 
Community representatives have an important role in providing information to and 
consulting with local communities in relation to drugs issues, as well as re-assuring 
them that the Task Force is operating on the basis of genuine partnership. It is 
recognised that support and networking of community representatives needs to be 
encouraged.  A crucial part of that role is their coming together to identify issues of 
common concern, so as to have a joint input and impact on policy development. They 
are assisted in this role by the TF Development Workers and by the DAG Community 
Representatives with assistance from Citywide Drugs Crisis Campaign with the process 
of establishing networks nationally, facilitating training and regular meetings of the 
Task Force community representatives. Where Community representatives are 
attending regional, national and network meetings as part of their role, the travel, 
subsistence and family care costs should be applied. Where possible, expenses should 
be kept to minimum e.g. holding sector meetings on the same day as TF meetings.  
Particular attention should be paid to supporting the community sector. 
 
Supports for Voluntary Sector Representatives 
 
The National Voluntary Drug Sector (NVDS) has established a national network of 
voluntary clusters and a national representative body.  This organisation provides the 
means for the sector to network nationally, support the local clusters and represent the 
interests of the sector on the various national fora whose remit includes substance 
misuse. All voluntary TF members would need to be part of this network. 
 
Training 
 
Training for Task Force members is essential to the success of the initiative, 
particularly as representatives from the voluntary, community and statutory sectors are 
being asked to work together in a new and innovative setting. Task Forces should 
regularly identify the training and development needs of their members, with a view to 
determining how these needs can best be met.  
 
Small Grants Fund 
 
The Small Grants Fund (RDTFs only) is designed primarily to respond to new 
situations not covered in the Task Force plans.  While the budget may be used to 
respond to specific or unanticipated situations, it may also be used to provide "seed" 
funding to new or emerging community or voluntary groups, as a pre-cursor to 
involving them more actively in the Task Force's overall drugs strategy at a later date.  
Small Grants are only available to community and voluntary groups, excluding 
statutory organisations except in exceptional circumstances and evidenced by local 
community involvement, for drug-specific activities. 
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DAG Liaison  
 
The Liaison person from DAG is a support to the Drugs Task Force, and is a link 
between the work of the DTF and the DAG.  Part of the role of the Liaison is to act as a 
conduit for information between the DTF and the DAG. 
 
Advertising / Publications  
 
Projects funded under any initiative in the National Drug Strategy must acknowledge 
the Department of Community, Equality and Gaeltacht Affairs as a source of funding. 
This applies to both printed material and signage, as appropriate. 
 
This provision must be included in all notifications of approval of funding to and from 
Channels of Funding/Project Promoters/Development Groups, etc: 
 
 For the standard requirements with regard to the NDP, see www.ndp.ie. 
 DTFs should acknowledge the role of the Department of Community, Equality and 
Gaeltacht Affairs in advertising / publications as, in Irish and/or English versions of 
the wording to be included is as follows – 
 
 “Maoinithe ag an Roinn Gnothaí Pobail, Comhionnanais agus Gaeltachta tríd an 
Tascfhorsa Reigiúnacha Drugaí (cuí).” 
 AND / OR  
      “Funded by the Department of the Community, Equality and Gaeltacht Affairs 
through the  
       (relevant) Drugs Task Force.” 
 
Signage Arrangements for Capital Projects  
For Capital Projects that have received funding under the Premises Initiative, 
arrangements are in place by the Department of Community, Equality and Gaeltacht 
Affairs for the recognition of Department funding by way of public signs. 
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SECTION VI 
 
 
Monitoring and Evaluation of 
Drugs Task Force projects 
 
 
Financial Procedures 
 
Revised financial procedures, reporting by Drugs Task Forces to the Office of the 
Minister for Drugs and the future of mainstreaming are expected to be the subject of 
circulars from the Office of the Minister for Drugs to Task Forces from time to time 
during 2011.  In the meantime, the principles set out below remain in place. 
 
 
Project Funding 
 
Funding is approved by the OMD on an annual basis.  The first tranche of funding is 
called initial funding.  Initial funding is approved on a ‘pro rata’ basis, based on the 
annual allocation approved for each project.  After the initial funding has been 
expended projects then go through an interim funding process.  It remains the intention 
of the Office of the Minister for Drugs that, unless specific difficulties emerge in 
relation to a particular project, it should continue to receive funding until it is evaluated 
formally and a decision is made on its continuation/mainstreaming.  Interim funding is 
approved by the OMD on an annual basis. 
 
If a Drugs Task Force wishes to reallocate funding between projects/actions, a proposal 
must be submitted to the OMD outlining the new project and the need for it, and why 
the funding is no longer required for what was originally approved.  This proposal must 
be fully developed, discussed and approved at Drugs Task Force level, with full 
agreement of all parties, prior to submission to the OMD. 
 
Conditions Under Which Funding is Allocated  
 
Funding to support proposals is being made available subject to the following 
conditions: 
 
 Funding will be allocated to support only those proposals specifically identified in 
the Drugs Task Force strategy, and named as those ‘recommended’ by the OMD, 
and approved for funding. 
 
 Funding will be provided on the basis of supporting the projects initially for a 
period of one year.  Projects which require funding to continue beyond one year 
will be reviewed by the Drugs Task Force prior to the end of that period in light of 
an evaluation of their effectiveness and impact on the drug problem in their area and 
taking account of whether funding should more appropriately be made available 
from a different source (through the DTF examination of theRDTF1/LDTF1 Form).  
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Continuation of funding via the OMD will be subject to a Government decision in 
relation to the process. 
 
 Where a project is being funded on a one-year basis, as opposed to a once-off grant, 
the profile of expenditure for the year (appended to the RDTF1/LDTF1 Form) 
should be completed.  In such cases, funding will be made available to the project 
promoter in advance instalments based on the profiles, which may be revised by the 
Funding Agency in consultation with the  Drugs Task Force, in the light of the 
examination of the detailed proposals and costings. 
 
 The project promoter must complete the RDTF1/LDTF1 Form and forward it to the 
Drugs Task Force, as well as furnishing any other information requested by the 
Task Force or the Funding Agency relevant to the proposal being funded. 
 
 The project promoter must satisfy the Drugs Task Force that appropriate 
management and personnel arrangements are in place to ensure that the proposal for 
which funding has been allocated can be successfully completed. 
 
 Salaries should be agreed with the DTF in accordance with the appropriate 
regulations and requirements of the channel of funding for that project. 
 
 The project promoter must comply with the tax and accounting requirements of the 
State Agency through which the funding is being channelled; 
 
Where the project promoter proposes to recruit staff in order to implement a proposal, it 
is expected that such posts will be filled through open competition.  Where a project 
promoter proposes to depart from this practice, due to exceptional circumstances, the 
prior consent of the OMD should be sought. 
 
 Normal public sector tendering arrangements should be applied as appropriate. 
 
 Reallocation of funding: Drugs Task Forces cannot reallocate any funding that is 
not spent within the current year without seeking formal approval from the OMD. 
 
 Administration fees by hosting agencies: as Drugs Task Forces are based on a 
partnership approach, hosting fees outside of actual administration costs for the 
administration of projects is not anticipated. In exceptional circumstances where 
such situations arise, such costs should be kept to a minimum in order to prioritise 
frontline services.  
 
Role of the Funding Agency 
 
The role of the Funding Agency will be to: 
 
 Ensure that the conditions under which funding has been approved are complied 
with; 
 
 Enter into an agreement/contract with the project promoter in respect of the funding 
which is being allocated; and 
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 Ensure that the projects are commenced on a viable basis within a set period of the 
date of allocation, with any funding of the projects not commenced within the 
period being deemed to be de-committed.  There must be a provision allowing for 
the recovery of any funding previously disbursed to de-committed projects. 
 
Reports are submitted to the Task Force coordinator by the project promoter on a 
quarterly basis, or more regularly where appropriate.  These reports record progress in 
relation to the project, as well as setting out the position in relation to expenditure and 
the drawdown of funding. 
 
If it becomes apparent that problems are developing with a particular project, the 
statutory representative on the Task Force within whose remit the project falls should, 
in association with the co-ordinator, enquire into the difficulties and report back to the 
Task Force and State Agency.  The Task Force as a whole must agree a position where 
continuing difficulties persist.  Where appropriate, OMD should be consulted.  Where 
there is any evidence or suggestion of financial impropriety, the State Agency should be 
informed immediately. 
 
Mainstreaming 
 
The term mainstreaming refers to the process by which responsibility for the funding of 
a project funded on an interim basis by Drugs Task Forces transfers when the project is 
evaluated to the relevant State Agency, in accordance with the laid down procedures 
and protocols. 
 
Projects will only be mainstreamed where they have been formally evaluated in 
accordance with the agreed criteria and, following this evaluation, there is a clear 
recommendation that they should continue.  It would also be essential that any 
modifications recommended in the evaluation (i.e., amended operating procedures, etc.) 
be put in place prior to any project being mainstreamed. 
 
Mainstreamed projects make a significant on-going contribution to the response to 
substance misuse problems in LDTF areas.  To maintain the strategic links between 
Drugs Task Forces and mainstreamed projects, it is recommended that the relevant 
funding body brief the Task Force on the activity of the project on an annual basis.   
 
 
. 
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Appendix 1 
 
Drugs Task Force Areas 
TASK  FORCE AREAS  COVERED 
Ballyfermot LDTF Ballyfermot 
Dublin 12 LDTF Crumlin, Drimnagh, Kimmage &  
Walkinstown 
Canal Communities LDTF  Bluebell, Inchicore & Rialto 
South Inner City LDTF Ringsend, Dublin 2 & 8 
North Inner City LDTF Dublin 1, 3 & 7 (part) 
Ballymun LDTF Ballymun 
Finglas/Cabra LDTF Finglas, Cabra 
Dublin North East LDTF Coolock, Darndale, Donnycarney & 
Killbarrack 
Blanchardstown LDTF Blanchardstown 
Clondalkin LDTF Clondalkin 
Tallaght LDTF Tallaght, Whitechurch 
Dun Laoghaire Rathdown LDTF  Dun Laoghaire Rathdown 
Bray LDTF Bray 
Cork City LDTF Cork City 
Midland RDTF Laois, Longford, Offaly & Westmeath 
Mid Western RDTF (incl. Limerick City 
Sub-Group) 
Clare, Limerick, Limerick City & 
Tipperary NR 
North Eastern RDTF East Cavan, Louth, Meath & Monaghan 
North Western RDTF Donegal, Leitrim, Sligo & West Cavan 
Southern RDTF Cork & Kerry 
South Eastern RDTF Carlow, Kilkenny, Tipperary SR, Waterford & Wexford 
Western RDTF Galway, Mayo & Roscommon 
East Coast RDTF East Wicklow 
North Dublin City & County RDTF North Dublin City & Fingal 
South Western RDTF South & West Dublin City, South Count 
Dublin,  Kildare & West Wicklow 
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Appendix 2 
 Principles Governing Line Management of RDTF staff by HSE 
Regional Drug Task Force Co-ordinators 
 
 Employment Contracts for Development/Administrative staff will be clearly 
with a legal entity e.g. a Partnership Company/community based company 
(Host Employer) which can enter into legal contracts.  
 The legal entity i.e. Partnership Company/Community based company   (Host 
Employer) already have well established employment policies/procedures in 
place. At no time will HSE policies/procedures be used **. 
 Development/Administrative contract holders will be clearly advised they 
have no linkages with HSE other than line management in the first instance 
 Issues arising from discharge of duties by Development/Administrative staff 
will be identified by the line manager (Drug Task Force Coordinator) and will 
be addressed as follows:  
Informal resolution:  
 Between the TF coordinator as line manager and post holder 
 If unresolved, a meeting(s) involving the TF chairperson, TF coordinator and 
post holder  
Formal process: 
 If unresolved, the legal entity i.e. the partnership of community- based 
company employment mechanisms to be pursued 
 Any dispute between the parties may subsequently be referred to national 
state industrial relations machinery.  
 
**- In the event of the TF choosing to become a legal entity and choosing to 
employ directly, it must ensure that it uses well-established employment 
policies. No staff will be employed until these are in place. 
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 Appendix 3 
 
Goodbody Expenditure Review Process Indicators 
 
DTF Board Meetings: Number and hours of DTF board meetings attended by sectors 
 
 
 
DTF Sub-Committee Meetings: Number and hours of DTF board meetings 
attended by sectors 
 
 
Overall DTF stakeholder satisfaction rating: 
 
 
  
 
Total no of Meetings 
 
Statutory reps   
Community reps  
Voluntary reps   
Co-ordinator               
Political reps   
Chairperson    
NDST Liaison   
Partnership  
Total no. of hours spent at meetings  
  
Total Number of meetings   
Voluntary reps   
Community reps   
Statutory reps   
Coordinator  
Chairperson    
Political reps   
Partnership  
NDST Liaison  
Avg No of hours spent at meetings  
Satisfaction  
Strongly satisfied  
Somewhat satisfied   
Undecided  
Somewhat dissatisfied   
Strongly dissatisfied   
No opinion  
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DTF Coordinator External Meetings: The annual number of non-project related 
meetings attended by the DTF Coordinator with entities external to the Task 
Force 
 
 
 
 
 
 
RDTF (including subgroups)  
Partnership (including Sub-Groups)  
RAPID  
Coordinators’ Network  
Cohesion Group/Local Dev 
Gp/Councils/CDP/SIMS 
 
NDST  
NDST Liaison  
SCP  
Coordinator and Chairs Network  
Project Committees/steering 
groups/management Groups 
 
Chairperson  
Staff/ Management Liaison  
Workshops  
Drug Education Programme  
CE Working Group  
Networks: Vol/Educational  
Prison Link  
Citywide  
HSE  
Community Forum   
Maynooth  
Research committee  
Website development  
Law Centre  
CDYSB  
Equal  
Other  
TOTAL No. of Meetings  
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Appendix 4 
 
Procedures for Mainstreaming (pre 2010) 
 
Evaluation Process 
 
The projects will be evaluated centrally once they have been piloted. The process shall 
be: 
 Examine the objectives of the projects selected and the extent to which these have 
been achieved. 
 Measure the outputs and, as far as practicable, the outcomes of the projects. 
 Provide an assessment report on the overall effectiveness of each project with 
particular reference to: 
o The achievements of the projects relative to the National Drugs Strategy pillars; 
o The level and nature of services provided; 
o Whether those services meet the defined needs of the Drugs Task Force areas as 
outlined in their plans; 
o The numbers attending, levels of attendees and the assistance provided by 
project. 
o The quality of that assistance; including the participants/service users own 
experience and perceptions.  
o The legal, financial and budgetary, and management structures of projects and 
their adequacies. 
o The identification of any critical factors (external and internal) affecting the 
delivery of the services. 
o The value for money being achieved. 
 
Protocols/Guidelines for Mainstreaming 
 
The following protocols/guidelines have been developed to provide a platform on 
which project promoters and State Agencies can enter into an arrangement for the 
continued operation and funding of projects on a mutually acceptable basis. 
 
It is vitally important that both sides’ rights and responsibilities are acknowledged and 
respected. The origins and ethos of individual projects should not be lost sight of. 
Equally, the expertise of State Agencies should be seen as an asset, while their 
responsibilities in relation to auditing of funding, etc. must also be recognised. 
 
The following are the protocols which must be observed if the mainstreaming process 
is to work effectively: 
 
 prior to mainstreaming, a contract/agreement should be drawn up between the 
project promoter and the State Agency and witnessed by the Drugs Task Force, 
which will outline the service to be delivered by the project and the funding, 
supports, etc. to be provided by the agency; 
 
 the introduction of changes to the project - either in terms of funding, nature, type 
or scale - can only be done following consultation between the three parties 
involved, i.e. the project promoter, the State Agency and the Drugs Task Force; 
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 the project promoter must respect the responsibility of the State Agency to 
account for Exchequer funding and must, therefore, comply with the agency’s 
reporting and auditing requirements; and 
 
 the State Agency must be assured that funding at an agreed level will be 
transferred to it simultaneously with its taking over responsibility for the project. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 - 46 - 
Appendix 5 
 
Drugs Task Force Action Plans:  Possible Issues for Consideration 
 
Action Plans 
Each Drugs Task Force should prepare an action plan to respond to the drug problem 
in their areas. Action plans should be designed to complement and add value to the 
drug programmes and services already being provided or planned by the State 
Agencies. The over-riding aim should be to provide a strategic, co-ordinated response 
to the drug problem in the Task Force area, through the development of a single, 
integrated plan, which all organisations and agencies - statutory, voluntary and 
community - support and are committed to implementing. A comprehensive 
consultation process is essential when preparing the plan. This should include 
consultation with local statutory, voluntary and community organisations which, 
although not represented on the Task Force, are nevertheless delivering programmes 
and services in the area relevant to addressing the overall drug problem. It is vitally 
important that local communities have an opportunity of inputting into the planning 
and development of proposals affecting their areas if they are to take ownership of the 
projects once they commence.  
 
 
Initiatives in the Action Plans 
The initiatives in the Task Force plans can be categorised under the broad themes of 
the pillars of the NDS. Examples of the types of measures funded include:  
• research into the extent and nature of the local drug problem, with a view to 
assessing the needs of local drug misusers;  
 
• the development of materials for delivering drug awareness messages relevant to 
local circumstances (e.g. videos, information leaflets, pamphlets, comics, painting 
books, etc.);  
 
• the setting up of local information and advice centres for drug misusers and their 
families;  
 
• measures to target special client groups which normal drug information services 
may not reach (e.g. Communities of Interest.);  
 
• the establishment of Community Drug Teams, to provide a holistic, inter-agency 
response to the needs of local drug misusers;  
 
 
When developing plans the following considerations may be taken into account: 
• children involved in or at risk of becoming involved in drugs; 
 
• the development of activities aimed at “at risk” children and young people outside 
the school setting (in youth clubs, etc.); 
 
• the development and/or expansion of premises through which community-based 
drug programmes and services can be delivered; 
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• the provision of training for community groups and individuals, to enable them to 
work with drug misusers, their families & Community of Interest; 
 
• the provision of training on drug issues for local services 
 
• ensuring that drug misusers have access to a continuum of treatment/rehabilitation 
options to meet their diverse needs; 
 
• the development of programmes and services for stabilised drug misusers, with the 
aim of fully re-integrating them into the community, including the use of initiatives, 
such as Community Employment, to achieve this aim;  
 
• the provision of support for families or the extended families of drug misusers, 
through advice and assistance; 
 
• to support and expand on the work of “link workers” to assist drug misusers at 
critical transitional periods (e.g. during prison sentences, moving from rehabilitation 
towards training/employment, etc.); 
/ 
• the development of new or specific services to cater for the diverse needs of drug 
misusers (e.g. crèche facilities for single parents, residential drug 
treatment/rehabilitation centres where parents can bring their children with them, 
etc.); 
 
• the establishment of mediation fora with a view to resolving local issues around 
supply in a balanced and equitable fashion. 
 
The statutory representatives on the Task Force - while having regard to data 
protection and any other relevant legislation - should ensure that all relevant 
information available to their organisations is provided to the Task Force for this 
purpose. Where a Task Force proposes to conduct or commission research into the 
/nature, extent or prevalence of drug misuse in its area, it is important that it has 
regard to accepted norms for the conduct of such research, taking into account the 
need to produce objective, valid and comparable data. It would be important, 
therefore, that research is conducted on the basis of a standardised approach and the 
Health Research Board should be consulted for guidance on this issue. 
  
Development and prioritisation of specific proposals to give effect to the strategy 
 
Having drafted a coherent strategy to respond to the local drug problem, the next step 
is to develop and prioritise a series of specific proposals to give effect to that strategy. 
In preparing these proposals, the Task Force should bear in mind that initiatives to fill 
gaps in service provision do not necessarily have to be funded through the Task 
Forces and the onus on State Agencies to deliver programmes and services in their 
own areas of responsibility remains. All proposals should be fully costed and 
prioritised. The Task Force should also pay particular attention to identifying any 
unnecessary overlap or duplication in current or planned service provision, proposals 
for the elimination of which should be agreed between the relevant parties and 
included in the plan. 
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Cross-Task Force issues 
In preparing its plan, the Task Force should identify issues which - while not 
impacting directly or exclusively on its area - are nevertheless important in 
developing an integrated, coherent response across all Task Force areas. An example 
of this is the issue of homeless drug users, a problem which some Task Force areas 
“export” while others “import”. 
The Task Force should: 
 
•   identify which issues need to be examined in this context; and  
 
• make recommendations as to how they might best be addressed. The Drugs 
Advisory Group will then consider these issues and - following further consultation 
with the Task Forces - will make recommendations to the Minister/Minister of State 
on the matter. 
 TION VI 
Evaluating /Assessing plans 
It is important that plans are evaluated /assessed to ensure that an effective response 
to the drug problem is being implemented in each area. 
 
The following are the criteria which will/may be used to assess the updated plans:  
 
• the extent to which the plan is area-based, integrated and maximises the use of 
existing resources; 
 
• whether the measures proposed are additional and complementary to existing or 
planned programmes and services - statutory, voluntary and community - in the area;  
 
• whether the proposed measures link effectively with complementary initiatives, 
existing or planned,  
 
• whether the Task Force has clearly demonstrated a partnership approach to filling 
gaps in service provision and eliminating duplication or overlap; 
 
• whether it has been clearly demonstrated that the proposed programmes and services 
meet the identified needs of the area, having regard to the extent and nature of the 
local drug problem, the diverse needs of the target group and the current or planned 
level of service provision; 
 
• whether the proposed measures accord with the aims, objectives and targets of the 
overall initiative; 
 
• the extent to which the proposed projects have the potential to be successfully 
mainstreamed following full piloting and evaluation; 
 
• whether the promoters have demonstrated the capacity to deliver the proposed 
projects; 
 
• whether the proposed projects are viable and sustainable; 
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• whether the plan incorporates new, innovative approaches in responding to the drug 
problem, which are capable of being replicated elsewhere; 
 
• whether the proposed projects have been fully costed and prioritised; 
 
• whether the proposed projects set out clear aims, objectives and targets, in terms of 
inputs and expected measurable outputs, outcomes and impacts; 
 
• whether the Task Force has demonstrated a wide consultation process in the 
development of the plan; and 
• the mechanisms proposed to ensure the effective implementation and monitoring of 
the approved proposals. 
 
Information sessions 
Taking account of the experienced gained to date is an important part of the 
preparation of the plans. Therefore, the Drug Advisory Group arranged a series of 
information sessions for the Task Forces to facilitate the dissemination of best 
practice under the various themes to be addressed in the plans. 
SECTION VII 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
